Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

16.58
+0.07540.46%
Volume:101.83K
Turnover:1.69M
Market Cap:225.43M
PE:-4.15
High:16.83
Open:16.48
Low:16.06
Close:16.50
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:0.56
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.77
PE(LYR):-2.66

Loading ...

Company Profile

Company Name:
Immunic, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
100
Office Location:
1200 Avenue of the Americas,Suite 200,New York,New York,United States
Zip Code:
10036
Fax:
- -
Introduction:
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Directors

Name
Position
Barclay Phillips
Lead Independent Director
Jon Congleton
Independent Director
Jorg Neermann
Independent Director
Michael Bonney
Chair of the Board
Richard Rudick
Independent Director
Simona Skerjanec
Independent Director
Tamar Howson
Independent Director
Thor Nagel
Independent Director
Daniel Vitt
Director
Duane Nash
Director

Shareholders

Name
Position
Erik Lundgren
Chief Executive Officer
Jason Tardio
Chief Operating Officer and President
Glenn Whaley
Chief Financial Officer
Hella Kohlhof
Chief Scientific Officer
Inderpal Singh
General Counsel
Michael Panzara
Chief Medical Officer
Patrick Walsh
Chief Business Officer
Werner Gladdines
Chief Development Officer